| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.22B | 140.70B | 119.82B | 111.11B | 93.09B | 106.61B |
| Gross Profit | 22.60B | 19.42B | 19.80B | 16.59B | 14.94B | 15.70B |
| EBITDA | 12.78B | 9.79B | 10.65B | 8.16B | 7.03B | 8.19B |
| Net Income | 7.62B | 5.64B | 6.46B | 4.51B | 4.84B | 3.29B |
Balance Sheet | ||||||
| Total Assets | 153.18B | 144.22B | 126.00B | 129.99B | 116.42B | 129.84B |
| Cash, Cash Equivalents and Short-Term Investments | 16.36B | 15.67B | 19.99B | 22.82B | 22.01B | 22.09B |
| Total Debt | 42.10B | 38.62B | 22.43B | 31.95B | 30.46B | 42.96B |
| Total Liabilities | 83.56B | 75.38B | 59.46B | 69.55B | 58.89B | 75.19B |
| Stockholders Equity | 69.61B | 68.83B | 66.53B | 60.43B | 57.53B | 54.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -18.04B | 7.83B | 1.47B | 13.24B | -7.50B |
| Operating Cash Flow | 0.00 | -17.19B | 10.23B | 4.15B | 15.84B | -6.76B |
| Investing Cash Flow | 0.00 | -255.00M | -1.18B | -3.07B | -1.55B | -220.00M |
| Financing Cash Flow | 0.00 | 13.15B | -11.86B | -253.00M | -14.35B | 15.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥116.65B | 10.36 | ― | 3.81% | 0.82% | 30.84% | |
79 Outperform | ¥89.35B | 15.89 | ― | 3.63% | 35.73% | 62.37% | |
75 Outperform | ¥131.73B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
69 Neutral | ¥115.22B | 11.04 | ― | 2.81% | -3.99% | 13.29% | |
68 Neutral | ¥124.77B | 11.19 | ― | 2.14% | 4.81% | -1.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥89.01B | 12.57 | ― | 8.02% | 2.51% | 4.02% |